US Patent 8003646 Substituted triazolo-pyridazine derivatives
Patent 8003646 was granted and assigned to Concert Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+436 characters)
Article
Patent abstract
This invention relates to novel substituted triazolo-pyridazines, their derivatives, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an α1-GABA-A receptor antagonist and/or a α2, α3 and α5 GABA-A receptor agonist.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08003646 Substituted triazolo-pyridazine derivatives US Patent 8003646 Substituted triazolo-pyridazine derivatives
Infobox
Patent Number
0800364600
Patent Number
800364600
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080036460
Date of Patent
August 23, 2011
0Patent Application Number
125503460
Date Filed
August 28, 2009
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080036460
Date of Patent
August 23, 2011
0Patent Application Number
125503460
Date Filed
August 28, 2009
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08003646 Substituted triazolo-pyridazine derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08003646
Date of patent
August 23, 2011
Patent application number
12550346
Date Filed
August 28, 2009
Patent primary examiner
Find more entities like US Patent 8003646 Substituted triazolo-pyridazine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
